Skip to main content
Erschienen in: International Journal of Colorectal Disease 7/2009

01.07.2009 | Original Article

Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry

verfasst von: Maurizio Ponz de Leon, Annalisa Pezzi, Piero Benatti, Antonio Manenti, Giuseppina Rossi, Carmela di Gregorio, Luca Roncucci

Erschienen in: International Journal of Colorectal Disease | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

A general improvement of colorectal cancer prognosis has been observed. Reasons of this more favourable trend are diffusion of screening, advancements in molecular biology, new developments in chemotherapy and surgical techniques. Through the data of a colorectal cancer registry, we purposed to evaluate changes in surgical procedures for colorectal neoplasms and to analyse trends of perioperative mortality.

Patients and methods

Patients with colorectal cancer were registered from 1984 to 2004. The main surgical procedures were recorded and classified. Perioperative mortality was defined as death of patients within 1 month since the operation.

Results

Regression analysis showed an increase over time of right and left hemicolectomy. Both colectomy and endoscopic polypectomy showed significant rise over time. In contrast, abdominoperineal operations dropped during the study period. A similar decrease was observed for palliative surgery. Perioperative mortality declined from 7–11% to 3–6% of all operations; main factors associated with perioperative mortality were presence of comorbidities, increasing age and advanced stage.

Conclusion

The better prognosis of patients with colorectal cancer was associated with changes of surgical techniques, with a tendency to prefer large operations over limited resections. Perioperative mortality showed a gradual decrease and is at present in the order of 3% to 6% of all operations.
Literatur
1.
Zurück zum Zitat Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, Manfredi S, Dancourt V, Faivre J (2002) Colon cancer in France: evidence for improvement in management and survival. Gut 51:60–64PubMedCrossRef Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, Manfredi S, Dancourt V, Faivre J (2002) Colon cancer in France: evidence for improvement in management and survival. Gut 51:60–64PubMedCrossRef
2.
Zurück zum Zitat Blomqvist P, Ekbom A, Nyrén O, Krusemo U, Bergström R, Adami HO (1997) Survival after colon cancer 1973–1990 in Sweden. Convergence between catchment areas. Ann Surg 2:208–216CrossRef Blomqvist P, Ekbom A, Nyrén O, Krusemo U, Bergström R, Adami HO (1997) Survival after colon cancer 1973–1990 in Sweden. Convergence between catchment areas. Ann Surg 2:208–216CrossRef
3.
Zurück zum Zitat Brenner H, Stegmaier C, Ziegler H (2005) Long-term survival of cancer patients in Germany achieved by the beginning of the third millennium. Ann Oncol 16:981–986PubMedCrossRef Brenner H, Stegmaier C, Ziegler H (2005) Long-term survival of cancer patients in Germany achieved by the beginning of the third millennium. Ann Oncol 16:981–986PubMedCrossRef
4.
Zurück zum Zitat Welch HG, Schwartz LM, Woloshin S (2000) Are increasing 5-year survival rates evidence of success against cancer? JAMA 283:2975–2978PubMedCrossRef Welch HG, Schwartz LM, Woloshin S (2000) Are increasing 5-year survival rates evidence of success against cancer? JAMA 283:2975–2978PubMedCrossRef
5.
Zurück zum Zitat Ponz de Leon M, Benatti P, Di Gregorio C, Fante R, Rossi G, Losi L, Pedroni M, Percesepe A, Roncucci L (2000) Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialised cancer Registry. Digest Liver Dis 32:312–317CrossRef Ponz de Leon M, Benatti P, Di Gregorio C, Fante R, Rossi G, Losi L, Pedroni M, Percesepe A, Roncucci L (2000) Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialised cancer Registry. Digest Liver Dis 32:312–317CrossRef
6.
Zurück zum Zitat Meissner HI, Breen N, Klabunde CN, Vernon SW (2006) Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 15:389–394PubMedCrossRef Meissner HI, Breen N, Klabunde CN, Vernon SW (2006) Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 15:389–394PubMedCrossRef
7.
Zurück zum Zitat Thompson MR, Steele RJC, Atkin WS (2006) Effective screening for bowel cancer: a United Kingdom perspective. Dis Colon Rectum 49:895–908PubMedCrossRef Thompson MR, Steele RJC, Atkin WS (2006) Effective screening for bowel cancer: a United Kingdom perspective. Dis Colon Rectum 49:895–908PubMedCrossRef
8.
Zurück zum Zitat Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK, US Multi-Society Task Force on Colorectal Cancer, American Cancer Society (2006) Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US multi-society task force on colorectal cancer and the American Cancer Society. Gastroenterology 130:1872–1885PubMedCrossRef Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, Bond JH, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex DK, US Multi-Society Task Force on Colorectal Cancer, American Cancer Society (2006) Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US multi-society task force on colorectal cancer and the American Cancer Society. Gastroenterology 130:1872–1885PubMedCrossRef
9.
Zurück zum Zitat Lynch HT, Boland CR, Gong G, Shaw TG, Lynch PM, Fodde R, Lynch JF, de la Chapelle A (2006) Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 14:390–402PubMedCrossRef Lynch HT, Boland CR, Gong G, Shaw TG, Lynch PM, Fodde R, Lynch JF, de la Chapelle A (2006) Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 14:390–402PubMedCrossRef
10.
Zurück zum Zitat Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, Leppert M, Slattery ML (2001) Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 10:917–923PubMed Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, Leppert M, Slattery ML (2001) Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 10:917–923PubMed
11.
Zurück zum Zitat Meyerhardt JA, Mayer RJ (2005) Systemic therapy for colorectal cancer. N Engl J Med 352:476–487PubMedCrossRef Meyerhardt JA, Mayer RJ (2005) Systemic therapy for colorectal cancer. N Engl J Med 352:476–487PubMedCrossRef
12.
Zurück zum Zitat Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R; German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740CrossRef Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R; German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740CrossRef
13.
Zurück zum Zitat Ky AJ, Sung MW, Milsom JW (1999) Research in colon and rectal cancer, with an emplasis on surgical progress. Dis Colon Rectum 42:1369–1380PubMedCrossRef Ky AJ, Sung MW, Milsom JW (1999) Research in colon and rectal cancer, with an emplasis on surgical progress. Dis Colon Rectum 42:1369–1380PubMedCrossRef
14.
Zurück zum Zitat Ruo L, Guillem JG (1999) Major 20th-century advancements in the management of rectal cancer. Dis Colon Rectum 42:563–578PubMedCrossRef Ruo L, Guillem JG (1999) Major 20th-century advancements in the management of rectal cancer. Dis Colon Rectum 42:563–578PubMedCrossRef
15.
Zurück zum Zitat Ponz de Leon M, Scapoli C, Zanghieri G, Sassatelli R, Sacchetti C, Barrai I (1992) Genetic transmission of colorectal cancer: exploratory data analysis from a population based registry. J Med Genet 29:531–538PubMedCrossRef Ponz de Leon M, Scapoli C, Zanghieri G, Sassatelli R, Sacchetti C, Barrai I (1992) Genetic transmission of colorectal cancer: exploratory data analysis from a population based registry. J Med Genet 29:531–538PubMedCrossRef
16.
Zurück zum Zitat Benatti P, Sassatelli R, Roncucci L, Pedroni M, Fante R, Di Gregorio C, Losi L, Gelmini R, Ponz de Leon M (1993) Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with “suspected HNPCC.” A population-based study in northern Italy. Colorectal Cancer Study Group. Int J Cancer 54:371–377PubMedCrossRef Benatti P, Sassatelli R, Roncucci L, Pedroni M, Fante R, Di Gregorio C, Losi L, Gelmini R, Ponz de Leon M (1993) Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with “suspected HNPCC.” A population-based study in northern Italy. Colorectal Cancer Study Group. Int J Cancer 54:371–377PubMedCrossRef
17.
Zurück zum Zitat Ponz de Leon M, Antonioli A, Ascari A, Zanghieri G, Sacchetti C (1987) Incidence and familial occurrence of colorectal cancer and polyps in a health-care district of northern Italy. Cancer 60:2848–2859PubMedCrossRef Ponz de Leon M, Antonioli A, Ascari A, Zanghieri G, Sacchetti C (1987) Incidence and familial occurrence of colorectal cancer and polyps in a health-care district of northern Italy. Cancer 60:2848–2859PubMedCrossRef
18.
Zurück zum Zitat Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Scalmati A, Roncucci L (1989) Familial aggregation of tumors in the three-years experience of a population-based Colorectal Cancer Registry. Cancer Res 49:4344–4348PubMed Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Scalmati A, Roncucci L (1989) Familial aggregation of tumors in the three-years experience of a population-based Colorectal Cancer Registry. Cancer Res 49:4344–4348PubMed
19.
Zurück zum Zitat Ponz de Leon M, Sassatelli R, Scalmati A, Di Gregorio C, Fante R, Zanghieri G, Roncucci L, Sant M, Micheli A (1993) Descriptive epidemiology of colorectal cancer in Italy: the 6-year experience of a specialised registry. Eur J Cancer 29:367–371CrossRef Ponz de Leon M, Sassatelli R, Scalmati A, Di Gregorio C, Fante R, Zanghieri G, Roncucci L, Sant M, Micheli A (1993) Descriptive epidemiology of colorectal cancer in Italy: the 6-year experience of a specialised registry. Eur J Cancer 29:367–371CrossRef
20.
Zurück zum Zitat Ponz de Leon M (1994) Prevalence of hereditary nonpolyposis colorectal carcinoma (HNPCC). Ann Med 26:209–214PubMedCrossRef Ponz de Leon M (1994) Prevalence of hereditary nonpolyposis colorectal carcinoma (HNPCC). Ann Med 26:209–214PubMedCrossRef
21.
Zurück zum Zitat World Health Organization (1992) International statistical classification of diseases and related health problems. WHO, Geneva Tenth Revision (ICD-10) World Health Organization (1992) International statistical classification of diseases and related health problems. WHO, Geneva Tenth Revision (ICD-10)
22.
Zurück zum Zitat SNOMED (1982) Systematized Nomenclature of Medicine, 2nd edn. College of American Pathologists, Skokie SNOMED (1982) Systematized Nomenclature of Medicine, 2nd edn. College of American Pathologists, Skokie
23.
Zurück zum Zitat Hutter RV, Sobin LH (1986) A universal staging system for cancer of the colon and rectum. Let there be light. Arch Pathol Lab Med 110:367–368PubMed Hutter RV, Sobin LH (1986) A universal staging system for cancer of the colon and rectum. Let there be light. Arch Pathol Lab Med 110:367–368PubMed
24.
Zurück zum Zitat Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRef Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRef
25.
Zurück zum Zitat Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient (II). Analysis and examples. Br J Cancer 35:1–39PubMed Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient (II). Analysis and examples. Br J Cancer 35:1–39PubMed
26.
Zurück zum Zitat Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351 (correction: 2001;20:655)PubMedCrossRef Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351 (correction: 2001;20:655)PubMedCrossRef
27.
Zurück zum Zitat Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Chichester, Wiley, New York Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Chichester, Wiley, New York
28.
Zurück zum Zitat Ponz de Leon M, Rossi G, di Gregorio C, De Gaetani C, Rossi F, Ponti G, Pecone L, Pedroni M, Roncucci L, Pezzi A, Benatti P (2007) Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. Intern Emerg Med 2:269–279PubMedCrossRef Ponz de Leon M, Rossi G, di Gregorio C, De Gaetani C, Rossi F, Ponti G, Pecone L, Pedroni M, Roncucci L, Pezzi A, Benatti P (2007) Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. Intern Emerg Med 2:269–279PubMedCrossRef
29.
Zurück zum Zitat Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, Miedema B, Ota D, Sargent D, National Cancer Institute Expert Panel (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583–596PubMedCrossRef Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, Miedema B, Ota D, Sargent D, National Cancer Institute Expert Panel (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583–596PubMedCrossRef
30.
Zurück zum Zitat Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC, EORTC Radiotherapy Group Trial 22921 (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123PubMedCrossRef Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC, EORTC Radiotherapy Group Trial 22921 (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123PubMedCrossRef
31.
Zurück zum Zitat Schmoll HJ, Sargent D (2007) Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard? Lancet 370:105–107PubMedCrossRef Schmoll HJ, Sargent D (2007) Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard? Lancet 370:105–107PubMedCrossRef
32.
Zurück zum Zitat Koopman M, Antonini NF, Douma J, Wals J, Honkoop AH, Erdkamp FL, de Jong RS, Rodenburg CJ, Vreugdenhil G, Loosveld OJ, van Bochove A, Sinnige HA, Creemers GJ, Tesselaar ME, Slee PH, Werter MJ, Mol L, Dalesio O, Punt CJ (2007) Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet 370:135–142PubMedCrossRef Koopman M, Antonini NF, Douma J, Wals J, Honkoop AH, Erdkamp FL, de Jong RS, Rodenburg CJ, Vreugdenhil G, Loosveld OJ, van Bochove A, Sinnige HA, Creemers GJ, Tesselaar ME, Slee PH, Werter MJ, Mol L, Dalesio O, Punt CJ (2007) Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet 370:135–142PubMedCrossRef
33.
Zurück zum Zitat Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG (2004) Enthusiasm for cancer screening in the United States. JAMA 291:71–78PubMedCrossRef Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG (2004) Enthusiasm for cancer screening in the United States. JAMA 291:71–78PubMedCrossRef
34.
Zurück zum Zitat Hakama M, Hoff G, Kronborg O, Påhlman L (2005) Screening for colorectal cancer. Acta Oncol 44:425–439PubMedCrossRef Hakama M, Hoff G, Kronborg O, Påhlman L (2005) Screening for colorectal cancer. Acta Oncol 44:425–439PubMedCrossRef
35.
Zurück zum Zitat Brief DK, Brener BJ, Goldenkranz R, Alpert J, Parsonnet V, Ferrante R, Huston J, Eisenbud D (1991) Defining the role of subtotal colectomy in the treatment of carcinoma of the colon. Ann Surg 213:248–252PubMedCrossRef Brief DK, Brener BJ, Goldenkranz R, Alpert J, Parsonnet V, Ferrante R, Huston J, Eisenbud D (1991) Defining the role of subtotal colectomy in the treatment of carcinoma of the colon. Ann Surg 213:248–252PubMedCrossRef
36.
Zurück zum Zitat Visser O, Bakx R, Zoetmulder FA, Levering CC, Meijer S, Slors JF, van Lanschot JJ (2007) The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam. J Surg Oncol 95:447–454PubMedCrossRef Visser O, Bakx R, Zoetmulder FA, Levering CC, Meijer S, Slors JF, van Lanschot JJ (2007) The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam. J Surg Oncol 95:447–454PubMedCrossRef
Metadaten
Titel
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry
verfasst von
Maurizio Ponz de Leon
Annalisa Pezzi
Piero Benatti
Antonio Manenti
Giuseppina Rossi
Carmela di Gregorio
Luca Roncucci
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 7/2009
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-009-0687-1

Weitere Artikel der Ausgabe 7/2009

International Journal of Colorectal Disease 7/2009 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.